• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基因表达序列分析对mRNA进行高通量差异筛选:甲状腺滤泡癌中三叶因子3 mRNA表达降低

High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas.

作者信息

Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N

机构信息

Department of Laboratory Medicine, Osaka University Graduate School of Medicine, D2, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.

出版信息

Br J Cancer. 2004 Apr 19;90(8):1600-5. doi: 10.1038/sj.bjc.6601702.

DOI:10.1038/sj.bjc.6601702
PMID:15083192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2409722/
Abstract

To find mRNAs whose expression differs between thyroid follicular adenomas and carcinomas, a high-throughput analysis of mRNAs in these two tumours was performed. This method, named high-throughput differential screening by serial analysis of gene expression (HDSS), combines a modified method of serial analysis of gene expression (SAGE) and real-time quantitative reverse transcription polymerase chain reaction (RT-PCR). A total of 40 candidate tag sequences that showed extremely different expression levels between a follicular carcinoma and a follicular adenoma in the SAGE analysis were analysed by real-time quantitative RT-PCR, using RNAs from an additional four typical follicular carcinomas and adenomas. One sequence tag that represents trefoil factor 3 (TFF3) mRNA showed a clear difference in its expression level between adenomas and carcinomas. The expression levels of TFF3 mRNA in 48 follicular adenomas and 29 follicular carcinomas were measured by real-time quantitative RT-PCR using a specific probe for TFF3. They were significantly decreased in follicular carcinomas, especially in widely invasive types and those with evident metastases. These results indicate that the decreased expression of TFF3 mRNA is a marker of follicular carcinomas, especially those with a high risk of invasion or metastasis.

摘要

为了找出甲状腺滤泡性腺瘤和癌之间表达存在差异的mRNA,对这两种肿瘤中的mRNA进行了高通量分析。这种方法称为基因表达序列分析高通量差异筛选(HDSS),它结合了改良的基因表达序列分析(SAGE)方法和实时定量逆转录聚合酶链反应(RT-PCR)。通过实时定量RT-PCR,使用另外4个典型滤泡癌和腺瘤的RNA,对在SAGE分析中显示滤泡癌和滤泡性腺瘤之间表达水平差异极大的40个候选标签序列进行了分析。一个代表三叶因子3(TFF3)mRNA的序列标签在腺瘤和癌之间的表达水平存在明显差异。使用TFF3特异性探针通过实时定量RT-PCR测量了48个滤泡性腺瘤和29个滤泡癌中TFF3 mRNA的表达水平。它们在滤泡癌中显著降低,尤其是在广泛浸润型和有明显转移的肿瘤中。这些结果表明,TFF3 mRNA表达降低是滤泡癌的一个标志物,尤其是那些具有高侵袭或转移风险的滤泡癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/2409722/b786c17fb41b/90-6601702f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/2409722/406b93994068/90-6601702f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/2409722/df631de36239/90-6601702f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/2409722/94790ec840ae/90-6601702f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/2409722/7982c307cf37/90-6601702f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/2409722/b786c17fb41b/90-6601702f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/2409722/406b93994068/90-6601702f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/2409722/df631de36239/90-6601702f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/2409722/94790ec840ae/90-6601702f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/2409722/7982c307cf37/90-6601702f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42ad/2409722/b786c17fb41b/90-6601702f5.jpg

相似文献

1
High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas.通过基因表达序列分析对mRNA进行高通量差异筛选:甲状腺滤泡癌中三叶因子3 mRNA表达降低
Br J Cancer. 2004 Apr 19;90(8):1600-5. doi: 10.1038/sj.bjc.6601702.
2
Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma.三叶因子3 mRNA与半乳糖凝集素-3 mRNA的相对表达水平降低可区分甲状腺滤泡癌与腺瘤。
Cancer Lett. 2005 Feb 28;219(1):91-6. doi: 10.1016/j.canlet.2004.07.004.
3
Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma.三叶因子3(TFF3):诊断甲状腺滤泡癌的一个有前景的指标。
Endocr J. 2009;56(1):9-16. doi: 10.1507/endocrj.k08e-105. Epub 2008 May 28.
4
STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates.STT3A、C1orf24、TFF3:细针吸取物中滤泡性甲状腺肿瘤特征性标志物。
Laryngoscope. 2011 May;121(5):983-9. doi: 10.1002/lary.21736.
5
Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.卷曲蛋白-1在甲状腺滤泡性肿瘤中表达下调,并调节肿瘤生长和侵袭能力。
J Pathol. 2008 May;215(1):87-96. doi: 10.1002/path.2331.
6
PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.PAX8和过氧化物酶体增殖物激活受体γ1基因在甲状腺良恶性组织中的表达状态
Eur J Endocrinol. 2004 Sep;151(3):367-74. doi: 10.1530/eje.0.1510367.
7
[Aspiration biopsy-nucleic acid diagnosis for widely used preparative testing].[用于广泛应用的制备性检测的抽吸活检-核酸诊断]
Rinsho Byori. 2012 Feb;60(2):132-8.
8
Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction.通过实时聚合酶链反应对正常和恶性甲状腺组织中雌激素受体-α和-β信使核糖核酸表达进行定量分析。
Oncology. 2001;61(4):293-8. doi: 10.1159/000055336.
9
Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours.过氧化物酶体增殖物激活受体(PPAR)γ在PAX8/PPARγ阴性甲状腺肿瘤中的表达下调。
Br J Cancer. 2004 Aug 16;91(4):732-8. doi: 10.1038/sj.bjc.6601989.
10
Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.甲状腺肿瘤细针穿刺活检(FNA)样本中的人端粒酶逆转录酶(hTERT)基因表达
Cancer Lett. 2003 Mar 10;191(2):223-7. doi: 10.1016/s0304-3835(02)00678-x.

引用本文的文献

1
Trefoil Factor Family (TFF) Peptides and Their Diverse Molecular Functions in Mucus Barrier Protection and More: Changing the Paradigm.三叶因子家族(TFF)肽及其在黏液屏障保护等方面的多样化分子功能:改变范式。
Int J Mol Sci. 2020 Jun 25;21(12):4535. doi: 10.3390/ijms21124535.
2
Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.用于鉴别甲状腺滤泡性良恶性肿瘤的基因表达(mRNA)标志物
Int J Mol Sci. 2017 Jun 2;18(6):1184. doi: 10.3390/ijms18061184.
3
Carbonic anhydrase 4 and crystallin α-B immunoreactivity may distinguish benign from malignant thyroid nodules in patients with indeterminate thyroid cytology.

本文引用的文献

1
Quantitative analysis of osteonectin mRNA in thyroid carcinomas.
Endocr J. 2002 Aug;49(4):511-6. doi: 10.1507/endocrj.49.511.
2
Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.通过定量逆转录-聚合酶链反应测定甲状腺乳头状癌中半乳糖凝集素-3信使核糖核酸的过表达
J Clin Endocrinol Metab. 2002 Oct;87(10):4792-6. doi: 10.1210/jc.2002-020390.
3
Quantitative analysis of thymosin beta-10 messenger RNA in thyroid carcinomas.甲状腺癌中胸腺素β-10信使核糖核酸的定量分析。
碳酸酐酶 4 和晶状体蛋白 α-B 免疫反应性可区分甲状腺细胞学不确定患者的良性和恶性甲状腺结节。
J Surg Res. 2014 Aug;190(2):565-74. doi: 10.1016/j.jss.2014.03.042. Epub 2014 Mar 22.
4
Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues.基于基因表达谱的福尔马林固定石蜡包埋组织在滤泡性甲状腺癌和腺瘤的分子鉴别诊断中的应用。
BMC Med Genomics. 2013 Oct 7;6:38. doi: 10.1186/1755-8794-6-38.
5
The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma.miR-221/222 簇、miR-10b 和 miR-92a 在转移性微小浸润滤泡状甲状腺癌中高度上调。
Int J Oncol. 2013 Jun;42(6):1858-68. doi: 10.3892/ijo.2013.1879. Epub 2013 Apr 2.
6
ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.ADM3、TFF3 和 LGALS3 是甲状腺良恶性肿瘤细针穿刺活检的有鉴别意义的分子标志物。
Br J Cancer. 2012 Jan 31;106(3):562-8. doi: 10.1038/bjc.2011.578. Epub 2012 Jan 5.
7
Validity of multiplex biomarker model of 6 genes for the differential diagnosis of thyroid nodules.用于甲状腺结节鉴别诊断的6基因多重生物标志物模型的有效性
Thyroid Res. 2011 Jun 27;4(1):11. doi: 10.1186/1756-6614-4-11.
8
A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping.一种用于区分甲状腺乳头状癌与良性病变的多基因方法:使用带有自抽样法的支持向量机进行基因选择。
Endocr Relat Cancer. 2007 Sep;14(3):809-26. doi: 10.1677/ERC-06-0048.
9
Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions.甲状腺结节细针穿刺抽吸物的微阵列分析能够准确地对良性和恶性病变进行分类。
J Mol Diagn. 2006 Sep;8(4):490-8; quiz 528. doi: 10.2353/jmoldx.2006.060080.
10
Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.甲状腺乳头状癌与正常甲状腺组织之间蛋白质表达的定量和定性差异。
Mol Carcinog. 2006 Aug;45(8):613-26. doi: 10.1002/mc.20193.
Jpn J Clin Oncol. 2002 Jul;32(7):229-32. doi: 10.1093/jjco/hyf054.
4
Decreased expression of glutathione peroxidase mRNA in thyroid anaplastic carcinoma.
Cancer Lett. 2002 Aug 8;182(1):69-74. doi: 10.1016/s0304-3835(02)00069-1.
5
Cancer-specific mRNAs in thyroid carcinomas: detection, use, and their implication in thyroid carcinogenesis.
Endocr J. 2002 Apr;49(2):97-107. doi: 10.1507/endocrj.49.97.
6
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles.甲状腺乳头状癌中的基因表达显示出高度一致的特征。
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15044-9. doi: 10.1073/pnas.251547398.
7
Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions.一种免疫诊断方法在改善甲状腺结节性病变术前诊断中的应用。
Lancet. 2001 May 26;357(9269):1644-50. doi: 10.1016/s0140-6736(00)04817-0.
8
Overexpression of kalpha1 tubulin mRNA in thyroid anaplastic carcinoma.
Cancer Lett. 2001 Jul 10;168(1):51-5. doi: 10.1016/s0304-3835(01)00509-2.
9
Gene expression profiles in thyroid carcinomas.甲状腺癌中的基因表达谱
Br J Cancer. 2000 Dec;83(11):1495-502. doi: 10.1054/bjoc.2000.1483.
10
PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].人类甲状腺癌中的PAX8-PPARγ1融合癌基因[已修正]
Science. 2000 Aug 25;289(5483):1357-60. doi: 10.1126/science.289.5483.1357.